semaglutide week 2 side effects Patel it Like it is: The long-term of taking Semaglutide Beginning Dosage in New

The available human data is mainly from small observational and retrospective studies showing that GLP-1 drugs appear safe and well tolerated in people with MS when used for diabetes or weight loss

While various treatment approaches exist, emerging research suggests that tesofensine may hold promise as a potential therapeutic option for eating disorders

In addition, in order for these drugs to become a public health tool for cancer treatment or prevention, more information would be necessary such as what cancers are most affected by GLP-1s, how long patients need to remain on therapy for the desired protection and whether benefits differ between different GLP-1 medications

Patients who received 5-mg injections lost roughly 12 pounds over 40 weeks, while patients who received 15 mg lost about 23 pounds of body weight